Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR)
| CAPS Rating |
|
|---|
TLCR
VS S&P 500 (SPY)
TLCR News and Commentary
- Six Stocks Snapped Up by Famous Hedge Funds, Boosted by Short Covering – SeekingAlpha
- Baxter International Passes This Key Test – The Motley Fool
- Merger Arbitrage Mondays: March 07, 2011 – SeekingAlpha
- Wall Street Breakfast: Must-Know News – SeekingAlpha
- 2nd UPDATE: CSL 1st Half Profit Falls On FX, Loss Of Swine Flu Sales – SmartMoney
- M&A sources – Blog at The Motley Fool
- Baxter: Earnings Preview – SeekingAlpha
- Talecris Biotherapeutics Passes This Key Test – The Motley Fool
- Are You Watching This Trend at Talecris Biotherapeutics? – The Motley Fool
This ticker is not currently Ratable.
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
13
Outperform
5
Underperform
All-Star Players
2
Outperform
3
Underperform
Wall Street
2
Outperform
0
Underperform
RSS Headlines
Fool UK
